Nitric oxide and cyclic nucleotides participate in the relaxation of diclofenac on rat uterine smooth muscle

General Pharmacology

Volumn 30, Issue 1, 1998, Pages 25-29

  Perez Vallina J R ^a   Menendez Antolin L ^a   Cantabrana, B ^a   Sanchez M ^a   Hidalgo, A ^a  

^a Faculty de Medicina   (Spain)

Author keywords

cAMP; Diclofenac; Nitric oxide; Rat uterus; Spasmolytic effect

Indexed keywords

1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC AMP; ADENOSINE 3',5' PHOSPHOROTHIOATE; ADENYLATE CYCLASE; CYCLIC NUCLEOTIDE; DICLOFENAC; GUANINE NUCLEOTIDE BINDING PROTEIN; LINSIDOMINE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; UTERUS RELAXATION;

EID: 0031986194     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00089-X     Document Type: Article

References (45)

1. Abramson S. and Weissmann G. (1989) The mechanisms of action of non-steroidal antiinflammatory drugs. Arthrit. Rheum. 32, 1-9.
2. Abramson S., Korchak H., Ludewig R., Edelson H., Haines K., Levin R. I., Herman R., Rider S., Kimmel S. and Weissmann G. (1985) Modes of action of aspirin-like drugs. Proc. Natl. Acad. Sci. USA 82, 7227-7231.
3. Batra S., Sjöberg N. O. and Thorbert G. (1978) Estrogen and progesterone interactions in the rabbit uterus in vivo after steroid administration. Endocrinology 102, 268-273.
4. Butt E., Eigenthaler M., Genieser H.-G. (1994) (Rp)-8-pCPT-cGMPS, a novel cGMP dependent protein kinase inhibitor. Eur. J. Pharmac. 269, 265-268.
5. Cantabrana B., Pérez Vallina J. R., Menendez L. and Hidalgo A. (1995) Spasmolytic and calmodulin inhibitory effect of non-steroidal anti-inflammatory drugs in vitro. Life Sci. 57, 1333-1341.
6. Cellek S., Kasakov L. and Moncada S. (1996) Inhibition of nitregic relaxations by a selective inhibitor of the soluble guanylate cyclase. Br. J. Pharmac. 118, 137-140.
7. Collier S. and Ghosh P. (1991) Comparison of the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on proteoglycan synthesis by articular cartilage explant and chondrocyte monolayer cultures. Biochem. Pharmac. 41, 1375-1384.
8. Cruz M. A., González C., Gallardo V., Albornoz J., Muñoz M. E. and Lagos M. (1995) Endothelial modulation of vascular tone and 5-hydroxytryptamine-induced responses in human chorionic atreries and veins. Gen. Pharmac. 26, 1571-1577.
9. Fernandez A. I., Cantabrana B. and Hidalgo A. (1992) Mediators involved in the rat uterus contraction in calcium-free solution. Gen. Pharmac. 23, 291-296.
10. Francis S. H. and Corbin J. D. (1994) Structure and function of cyclic nucleotide-dependent protein kinases. Ann. Rev. Physiol. 56, 237-272.
11. 2+ Pump of Plasma Membranes (Edited by Rega A. F. and Garrahan P. J.), pp. 153-164. CRC Press, Boca Raton, FL.
12. Gnegy M. E. (1993) Calmodulin in neurotransmitter and hormone action. Ann. Rev. Pharmac. Tox. 32, 45-70.
13. Govantes C., Rodríguez-Martínez M. A. and Marín J. (1996) Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery. Meth. Find. Exp. Clin. Pharmac. 18, 387-395.
14. Greene I. M., Arifullah M. and Kenny A. D. (1992) Carbonic anhydrase inhibition by flurbiprofen and related agents. Pharmacology 45, 278-284.
15. Insel P. A. (1990) Analgesic-antipyretic and anti-inflammatory agents: drugs employed in the treatment of rheumatoid arthritis and gout. In The Pharmacological Basis of Therapeutics (Edited by Goodman Gilman A., Rail T. W., Nies A. S. and Taylor P.), 8th Ed., pp. 638-681. Pergamon Press, New York.
16. Leroy M. J., Cedrin I., Breuiller M., Giovagrandi Y. and Ferre F. (1989) Correlation between selective inhibition of the cyclic nucleotide phosphodiesterase and the contractile activity in human pregnant myometrium near term. Biochem. Pharmac. 38, 9-15.
17. Lindgren S. and Andersson K.-E. (1991) Comparison of the effects of miltinone and OPC 3911 with those of isoprenaline, forskolin and dibutyryl-cAMP in rat aorta. Gen. Pharmac. 22, 617-624.
18. Marone G., Columbo M., Poto S., Giugliano R. and Condorelli M. (1996) Possible role of calmodulin in the control of histamine release from human basophil leukocytes. Life Sci. 39, 911-922.
19. Means A. R., Nanberkum M. F. A., Bagchi I., Lu K. P. and Rasmussen C. D. (1991) Regulatory functions of calmodulin. Pharmac. Ther. 50, 255-270.
20. Moncada S., Palmer R. M. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmac. Rev. 43, 109-142.
21. Moro M. A., Russell R. J., Celleck S., Lizasoain I., Su Y., Darley-Usmar V. M., Radomski M. W. and Moncada S. (1996) cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad Sci. USA 93, 1480-1485.
22. Mühl H., Kunz D. and Pfeilschifter J. (1994) Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br. J. Pharmac. 112, 1-8.
23. Murray K. J. (1990) Cyclic AMP and mechanisms of vasodilation. Pharmac. Ther. 47, 329-345.
24. Nakaya Y., Yamamoyo S., Hamada Y, Kamada M., Aono T. and Niwa M. (1996) Inducible nitric oxide synthase in uterine smooth muscle. Life Sci. 58, PL249-PL256.
25. Nechay B. R. (1984) Mechanisms of action of vanadium. Ann. Rev. Pharmac. Tox. 24, 501-524.
26. Nishimura M., Awano H. and Yagasaki O. (1989) Sodium salicylate facilitates calcium-dependent release of transmitter at mouse neuromuscular junctions. Br. J. Pharmac. 97, 1239-1245.
27. 2 on the induction of nitric oxide-and prostanoid-forining pathways in cultured rat mesangial cells. Biochem. J. 313, 617-623.
28. Ohishi K., Suzuchi T. and Uchida M. K. (1985) Relation between inhibition of calmodulin and mediator from rat mast cells. Gen. Pharmac. 16, 335-339.
29. Pallapies D., Peskar B. A., Brune K. and Zeilhofer H. U. (1994a) Modulation of nitric oxide effects by flurbiprofen enantiomers and nefopam and its relation to antinoceception. Eur. J. Pharmac. 271, 335-340.
30. Pallapies D., Burchert M., Peskar B. A., Debinska-Kiec A. and Peskar B. M. (1994b) Effect of 5-aminosalicylic acid and 4-aminosalicylic acid on precontracted rat aortic strips and on NO-mediated inhibition of platelet aggregation. Agents Actions 41, C235-C237.
31. Pérez Vallina J. R., Cantabrana B. and Hidalgo A. (1991) Mechanisms involved in the effects of phenidone, diclofenac and ethacrynic acid in rat uterus in vitro. Gen. Pharmac. 22, 435-441.
32. Pérez Vallina J. R., Cantabrana B. and Hidalgo A. (1995a) Calcium and G-protein related spasmolytic effect of non-steroidal and-inflammatory drugs on rat uterus contractions in vitro. Pharmacology 50, 324-332.
33. Pérez Vallina J. R., Menendez L., Cantabrana B. and Hidalgo A. (1995b) Involvement of cAMP in the spasmolytic effect of diclofenac on rat uterine smooth muscle. Pharm. Sci. 1, 185-187.
34. Pérez Vallina J. R., Menendez Antolin L., Cantabrana B., Sanchez M. and Hidalgo A. (1995c) Involvement of sodium/calcium exchange in the diclofenac-induced spasmolytic effect on rat uterus. Gen. Pharmac. 26, 1249-1253.
35. Rubio E., Estañ L., Morales-Olivas F. J. and Martínez-Mir M. I. (1993) Histamine inhibits spontaneous activity of the uterus of the progesterone-treated rat. J. Auton. Pharmac. 13, 395-402.
36. Sadeghi-Hashjin G., Folkerts G., Henricks P. A. J., Van de Loo P. G. F., Dik I. E. M. and Nijkamp F. P. (1996) Relaxation of guinea-pig trachea by sodium nitroprusside: cyclic GMP and nitric oxide not involved. Br. J. Pharmac. 118, 466-470.
37. 2+-free contraction of rat uterine smooth muscle with EGTA and drugs. Gen. Pharmac. 13, 393-399.
38. Salaices M., De Gregorio A. and Marín J. (1985) Study of vasodilator effects of papaverine, adenosine and related drugs in isolated cat cerebral arteries. Gen. Pharmac. 16, 633-636.
39. Seamon K. B. and Daly J. W. (1986) Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Res. 20, 1-150.
40. Umeki S. (1990) Effects of non-steroidal anti-inflammatory drugs on human neutrophil NADPH oxidase in both whole cell and cell-free systems. Biochem. Pharmac. 40, 559-564.
41. Urquart E. (1991) A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity. Agents Actions 32, 261-265.
42. Vane J. R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 231, 232-235.
43. Walsh M. P. (1991) Calcium-dependent mechanisms of regulation of smooth muscle contraction. Biochem. Cell. Biol. 69, 771-800.
44. Weissmann G. (1991) The action of NSAIDs. Hosp. Prac. 26, 60-76.
45. Wray S. (1993) Uterine contraction and physiological mechanisms of modulation. Am. J. Physiol 264, C1-C18.